Trends

Dr Reddy’s To Supply 100 Million Doses Of Russia Corona Vaccine

Published by

Dr Reddy’s Laboratories and Russian Direct Investment Fund (RDIF) have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.

Upon regulatory approval in India, Russia’s sovereign wealth fund will supply 100 million doses of the vaccine to Dr Reddy’s. The Sputnik V vaccine, which is based on well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the coronavirus pandemic.
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.

The agreement between RDIF and Dr Reddy’s reflects growing awareness of countries and organisations to have a diversified anti-Covid vaccine portfolio to protect their populations.

“India is among the most severely impacted countries from Covid-19 and we believe our human adenovirus dual vector platform will provide a safe and scientifically validated option to India in the battle against it,” said Kirill Dmitriev, Chief Executive Officer of RDIF.

G V Prasad, Co-Chairman and Managing Director of Dr Reddy’s said Sputnik V vaccine could provide a credible option in our fight against Covid-19 in India.

“The phase one and two clinical trials have shown promising results. We will be conducting phase three trials in India to ensure safety and efficacy for the Indian population,” he said in a statement.

Source: (ANI)

This post was last modified on 16 September 2020 5:28 pm

Share
Show comments
Published by

Recent Posts

Hyd Welcomes Transgender Traffic Police From Today

From today, transgender individuals will be assigned traffic duties in Hyderabad as part of a…

12 minutes ago

Gangster in Hiding Caught While Watching Pushpa 2

Pushpa 2 is currently the trending film on social media. Not just because of the…

47 minutes ago